sumatriptan has been researched along with Injury, Myocardial Reperfusion in 1 studies
Sumatriptan: A serotonin agonist that acts selectively at 5HT1 receptors. It is used in the treatment of MIGRAINE DISORDERS.
sumatriptan : A sulfonamide that consists of N,N-dimethyltryptamine bearing an additional (N-methylsulfamoyl)methyl substituent at position 5. Selective agonist for a vascular 5-HT1 receptor subtype (probably a member of the 5-HT1D family). Used (in the form of its succinate salt) for the acute treatment of migraine with or without aura in adults.
Excerpt | Relevance | Reference |
---|---|---|
"Treatment with sumatriptan significantly increased the endothelial nitric oxide synthase (eNOS) expression consequences nitric oxide metabolites' level in I/R rats." | 5.51 | Sumatriptan protects against myocardial ischaemia-reperfusion injury by inhibition of inflammation in rat model. ( Azizi, Y; Dehpour, AR; Dehpour, S; Faghir-Ghanesefat, H; Ghahremani, MH; Keshavarz-Bahaghighat, H; Rahimi, N; Sepand, MR; Sheibani, M, 2019) |
"Treatment with sumatriptan significantly increased the endothelial nitric oxide synthase (eNOS) expression consequences nitric oxide metabolites' level in I/R rats." | 1.51 | Sumatriptan protects against myocardial ischaemia-reperfusion injury by inhibition of inflammation in rat model. ( Azizi, Y; Dehpour, AR; Dehpour, S; Faghir-Ghanesefat, H; Ghahremani, MH; Keshavarz-Bahaghighat, H; Rahimi, N; Sepand, MR; Sheibani, M, 2019) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sheibani, M | 1 |
Faghir-Ghanesefat, H | 1 |
Dehpour, S | 1 |
Keshavarz-Bahaghighat, H | 1 |
Sepand, MR | 1 |
Ghahremani, MH | 1 |
Azizi, Y | 1 |
Rahimi, N | 1 |
Dehpour, AR | 1 |
1 other study available for sumatriptan and Injury, Myocardial Reperfusion
Article | Year |
---|---|
Sumatriptan protects against myocardial ischaemia-reperfusion injury by inhibition of inflammation in rat model.
Topics: Animals; Cardiotonic Agents; Inflammation; Lipid Peroxidation; Male; Myocardial Reperfusion Injury; | 2019 |